Victory Capital Management Inc Harrow Health, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$8.5 - $12.0 $91,587 - $129,300	-10,775 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$6.99 - $10.6 $1,076 - $1,632	-154 Reduced 1.41%	10,775 $98,000
Q2 2021 Aug 03, 2021	BUY	$6.68 - $11.07 $3,800 - $6,298	569 Added 5.49%	10,929 $102,000
Q1 2021 May 04, 2021	BUY	$6.26 - $11.03 $64,853 - $114,270	10,360 New	10,360 $70,000
Q2 2020 Aug 07, 2020	SELL	$3.61 - $6.47 $15,743 - $28,215	-4,361 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$3.5 - $7.31 $343 - $716	-98 Reduced 2.2%	4,361 $17,000
Q4 2019 Feb 04, 2020	BUY	$4.6 - $7.88 $50 - $86	11 Added 0.25%	4,459 $26,000
Q3 2019 Nov 12, 2019	BUY	$4.89 - $8.0 $21,750 - $35,584	4,448 New	4,448 $25,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.